Ketogenic diet trials – December 2017 update
I am pleased to note that more and more of the major cancer centers are taking interest in ketogenic diet trials.
The trials cover a vast amount of topics, including neurologic disorders, sleep apnea, autism, migraine, and of course, cancer. A quick search brought up 84 registered trials in total. https://clinicaltrials.gov/ct2/results?cond=ketogenic+diet&term=&cntry1=&state1=&recrs=
As of my last research trial search on www.clinicaltrials.gov, there are 21 total registered ketogenic diet trials for cancer. Out of the 21, 10 are devoted to brain cancers, 8 are actively recruiting, one study for non small cell lung cancer has closed, another for pancreatic cancer is likewise no longer recruiting, and one prostate cancer trial is still seeking applicants.
Majority of the ketogenic diet trials are studying brain tumors
The Midatlantic Epilepsy and Sleep Center in Bethesda Maryland has a trial of the Ketogenic Diet as adjunctive treatment (given after surgery) in brain cancers that relapse. They are looking for the Glioblastoma type of brain cancer, which as we know is a very aggressive type of brain tumor. NCT01865162 Clinicaltrials.gov identifier number. Contact Pavel Klein MD 301-530-9744 email kleinp@epilepsydc.com
Nicklaus Children's Hospital ( AKA Miami Children's Hospital) in Miami Florida is studying the effect of a ketogenic diet in children with malignant brain tumors. NCT03328858Clinicaltrials.gov identifier number ; Contact Jennifer Careers, MS, RDN 786-624-4854 jennifer.caceres@mch.com or Jenny Esteves 786-624-2854 or by email: jenny.esteves@mch.com
Newly diagnosed Malignant Glioma (brain tumor) patients can check out NCT03278249, a safety and feasibility study of the Modified Atkins Diet in treatment of Newly diagnosed malignant glioma at the University of Cincinnati Cancer Institute, Ohio. This study will examine whether patients can successfully produce ketones while on the Atkins diet. Contact the UC Cancer Institute Clinical Trials Office 513-584-7698 email: castle@ucmail.uc.edu
Michigan State University/Sparrow Hospital in East Lansing, Michigan- Dr. Kenneth Schwartz is doing a pilot study of the energy restricted (this is also ketogenic) diet in Glioblastoma Multiform, the most common brain tumor in adults. They will offer the diet in addition to standard of care surgery, radiation and chemotherapy to see whether the diet will add to the efficacy of the therapy and perhaps improve outcomes/delay relapse. NCT 01535911 Contact Dr. Schwartz at 517 975 9547 email: ken.schwartz@hc.msu.edu or Dr. Mary Noel PhD 517 884 0451 email: mary.noel@hc.msu.edu
The University of Liverpool in the United Kingdom is studying "Ketogenic Diets as an Adjuvant therapy in Glioblastoma. " NCT03075514 clinical trials.gov identifier number. They plan to recruit newly diagnosed brain cancer patients with Glioblastoma and after dividing them into two groups, assign one group the modified ketogenic diet (MKD) and the other, a medium chain triglyceride ketogenic diet (MCT). Per their description on the clinicaltrials.gov website, both diets follow the same high fat, low carbohydrate principles, with the MCT diet requiring the patient to consume some fat as a drink instead of solid food. The diet trial will run over 12 weeks. Contact Kirsty J. Martin, MSc, RD +44 (0) 151 529 5593 email: kirsty.martin@liverpool.ac.uk or contact the University of Liverpool +44 (0) 151 794 2000
Other Ketogenic Diet trials (Breast, Colorectal, prostate, uterine, head and neck, lymphoma
Memorial Sloan Kettering in New York City is recruiting overweight or obese patients with uterine cancer to participate in a ketogenic diet study. This study is actively recruiting. NCT03285152 Clinicaltrials.gov identifier number Contact Vicky Makker MD 646-888-4224 email: makkerv@mskcc.org or Dr. Abu-Rustum MD 212-639-7051
Prostate cancer patients can try to contact the University of Maryland in Baltimore. Their pilot study is looking for overweight prostate cancer patients to monitor over 8 weeks. They plan to check blood chemistries while on the ketogenic diet. Tests like testosterone, cholesterol, glucose,and other biomarkers are to be followed via blood testing during those 8 weeks to see if treatment can be delayed by a ketogenic diet. NCT03194516 Clinicaltrials.gov identifier number. Unfortunately they are recruiting by invitation only.
Albert Einstein College of Medicine in the Bronx, New York, has a trial but it still isn't recruiting. It is planning to enroll breast cancer patients. NCT02744079 Clinical trials.gov identifier number. Dr. Eugene Fine 718-904-2639 eugene.fine@einstein.yu.edu or Dr. Joseph Sparano MD 718-405-2555 email: jsparano@montefiore.org
Elsewhere, in Germany, A radiation oncology group is recruiting patients with either breast, rectal or head and neck cancers to participate in the ketogenic diet while receiving radiation therapy, and study potential body changes ( weight, glucose, etc) while on the diet. It appears to be similar to a safety / feasibility type of trial. NCT02516501 clinicaltrials.gov identifier number. Contact Dr. Reinhart Sweeney MD +49 9721 7206420 email: rsweeney@leopoldina.de or Dr. Rainer J. Klement , PhD +49 9721 7206424 rklement@leopoldina.de
Lastly, Chinese investigators at the Beijing Tiantan Hospital , Beijing China are planning but not yet recruiting a study of the ketogenic diet in patients with primary central nervous system (BRAIN AND SPINAL CORD) lymphoma. THey plan to add the ketogenic diet to high dose methotrexate chemotherapy . Contact Dr. Song Lin, M.D. 861067096509 linsong2005@126.com or Dr. Chun Zeng MD 861067096509 zengchun79@aliyun.com

